PRuDENTE; Diabetes Prevention Via Exercise, Nutrition and Treatment
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The PRuDENTE study proposes to assess if metformin therapy a viable, efficient and
cost-effective intervention to decrease the incidence of type 2 diabetes (DMT2) in adult
subjects with obesity and pre-diabetes in Mexico City. Half of the individuals recruited will
receive as intervention, metformin and lifestyle modification therapy and the other half will
receive only lifestyle modification therapy.
Phase:
N/A
Details
Lead Sponsor:
Instituto Nacional de Salud Publica, Mexico
Collaborators:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Ministry of Health, Mexico City University of California, San Francisco